Einstein Healthcare network

Philadelphia, Pennsylvania 19141

0 studies enrolling now · 12 studies all time

What they study most

Alcoholic Hepatitis, Atrial Fibrillation, Benign Prostatic Hyperplasia, Compensated Cirrhosis, Coronary Artery Disease, End Stage Liver Disease, Hepatic Cirrhosis, Hepatitis B, Chronic, Liver Cirrhosis, Non Alcoholic Steatohepatitis (NASH), Nonalcoholic Steatohepatitis, Peripheral Arterial Disease

Studies at this site

• Role of Prophylactic Postoperative Antibiotics in HoLEP — Withdrawn before enrolling
• Hybrid Coronary Revascularization Trial — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis — Completed
• Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee Arteries — Completed
• Monitoring of Symptoms and Cognitive Function Using Telehealth — Completed
• Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH) — Stopped early
• Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay — Completed
• Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) — Completed
• A Study of IDN-6556 in Subjects With Liver Cirrhosis — Completed
• Use of Platelet Rich Plasma Therapy for Acute Ankle Sprains in the Emergency Department — Completed